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Abstract
Background: 9p duplication is a structural chromosome abnormality, described in more than 150 patients to date.
In most cases the duplicated segment was derived from a parent being a reciprocal translocation carrier. However,
about 15 cases with de novo 9p duplication have been reported previously. Clinically, this condition is characterized
by mental retardation, short stature, developmental delay, facial dysmorphism, hand and toe anomalies, heart
defects and/or ocular manifestations.
Case presentation: We report here the case of a 2-year-old Moroccan girl with a de novo duplication of 9p24 to
p12. Clinical manifestations included failure to thrive, psychomotor delay, microcephaly, dysmorphic features,
equinus feet, and umbilical hernia. Further clinical investigations showed an insulin-like growth factor type 1
deficiency. Banding cytogenetics identified a derivative chromosome 9, with an abnormally elongated short arm.
Molecular cytogenetics based on multicolor banding probes characterized an inverted duplication 9p24 to p12 involving
several genes especially an insulin-like growth factor binding protein named insulin-like growth factor binding protein-like
1, which seemed to be overexpressed, leading to the insulin-like growth factor deficiency in our patient.
Conclusions: This study showed that insulin-like growth factor type 1 deficiency can be another feature of 9p duplication,
suggesting a likely involvement of insulin-like growth factor binding protein-like 1 overexpression in growth delay.
However, further studies of the gene expressions are needed to better understand the phenotype-karyotype correlations.
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Background
9p duplication is a structural chromosome abnormality
first described by Rethoré and colleagues [1]. To date
more than 150 cases have been reported; however, the
duplication is often due to a parental reciprocal balanced
translocation, that is, beside the 9p duplication another
chromosomal region is present in one copy only [2]. De
novo duplications of this chromosomal region have been
described in only about 15 cases, up to now [3–9].
Nonetheless, clinically this is a recognizable spectrum
with specific major features like failure to thrive, psycho-
motor delay, mental retardation, craniofacial abnormalities
(microcephaly, downslanting palpebral fissures, deep-set
eyes, hypertelorism, bulbous nose, short philtrum, down-
turned corners of the mouth, short neck), digital abnor-
malities (fifth finger clinodacyly, brachydacyly, dysplastic
nails), as well as skeletal malformations [10]. Here, we
describe a case of a patient admitted for different clin-
ical problems including insulin-like growth factor type
1 (IGF-1) deficiency with partial trisomy of 9p.
Case presentation
Our patient, a 2-year-old girl, was the third child of
healthy nonconsanguineous parents of Moroccan origin,
born at term after an uneventful 39-week gestation and
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normal delivery; she was admitted for genetic evaluation
because of psychomotor delay and failure to thrive. Her
birth weight was 2500 g (3rd centile), length was 46 cm
(3rd centile), and head circumference was 32 cm (3rd
centile). Her family history was unremarkable for devel-
opmental delay or recurrent miscarriages. The proposita
sat at 18 months, but her walking and language acquisi-
tion were delayed. On clinical examination, her length,
weight, and head circumference at 2 years old were as
follows: 68 cm (<3rd centile), 8 kg (<3rd centile) and 44
cm (<3rd centile). She had mild dysmorphic features
similar to that of the 9p duplication syndrome. She had
hypertelorism, deep-set eyes, broad nasal bridge and
bulbous nasal tip, short philtrum, downturned mouth, ret-
rognathia, and short neck. Additional findings included
large anterior fontanelle, fifth finger clinodactyly, left equi-
nus foot, and umbilical hernia. Further evaluation revealed
growth hormone deficiency with decreased serum level of
IGF-1, estimated at 47 ng/mL; whereas normal values are
between 51 and 327 ng/mL. Magnetic resonance imaging
(MRI) scan of pituitary gland was normal.
Cytogenetic analysis
Chromosomal analysis was performed on cultured periph-
eral lymphocytes of our patient and her parents according
to standard methods. R banding at the resolution level of
400 bands was performed, as well as C banding after bar-
ium hydroxide treatment. RHG analysis (R-banding of
human chromosomes by heat denaturation and Giemsa
staining) showed a derivative of chromosome 9 with a 9p
arm notably expanded. The extra band was C banding
negative, thus excluding pericentric inversion of the 9qh
region. This was interpreted as representing either a 9p
duplication or some other rearrangement. Since parental
karyotypes were both normal, our patient’s karyotype was
designated as 46,XX,der(9)?dn (Fig. 1).
Thereafter, fluorescence in situ hybridization (FISH)
test was done, applying multicolor banding probe set for
chromosome 9 [11]. Probe labeling, hybridization post
washing, signal detection, and image acquisition were
performed as previously reported [12, 13]. For
characterization of the heteromorphic patterns of
chromosome 9, further probe set was applied [14, 15].
Cytogenetic results
FISH experiments identified the extra segment as a dupli-
cation of 9p24 to 9p12. The karyotype could be character-
ized after the application of the probes mentioned above.
There was a partial trisomy 9p24 to 9p12. The region 9p24
to 9p12 was duplicated and inserted inverted in 9p12~13
(Fig. 2). The final karyotype was designated as follows:
46,XX,der(9)(pter->p12~13::p12->p24::p12~13->qter)dn.
Discussion
Even though 9p duplication is a well-described syn-
drome, there are only few cases where the duplicated
Fig. 1 RHG banding (400-band resolution) shows a derivative 9 chromosome with an abnormally elongated p arm
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fragment is not inherited due to a parental balanced
translocation. Table 1 shows clinical findings of patients
reported in the literature with pure de novo 9p24p12
duplication [4, 16, 17]. The phenotype of our patient
was consistent with the clinical spectrum described in
the other comparable cases. However, she lacked hypo-
plastic nails, brachydactyly and strabismus. Only our
patient presented with umbilical hernia, which is an un-
common finding and rarely reported [18]. Short stature
has been reported infrequently in these patients, and
IGF-1 deficiency specifically has only been seen twice
before [19, 20].
FISH-based banding methods allowed us to
characterize the 9 chromosome rearrangement as a pure
Fig. 2 Fluorescence in situ hybridization result after application of WCP 9 and MCB9, 9 alpha-satellite probe, and satellite III probe, midi36 probe
specific for 9p12 and 9q13-21.1. RP11-128P23 in 9p12 and RP11-430C15 in 9q13 confirmed that the region 9p24 to 9p12 was duplicated and
inserted inverted in 9p12~13
Table 1 Clinical features in patients with de novo 9p12p24 duplication
First author of reference Duplication 9p Congenital abnormalities
Our patient p12-p24 inverted - Microcephaly, large anterior fontanel - Short stature, psychomotor delay - Hypertelorism,
deep-set eyes, down-set ears, bulbous nose tip, broad nasal bridge, short philtrum,
downturned corners of the mouth, retrognathia, short neck - Fifth finger clinodactyly, left foot
equinus - Umbilical hernia. - Growth hormone deficiency
Cuoco et al., 1982 [16] p12-p24 tandem - Short stature, psychomotor retardation, puberty delay, Mental retardation - Hypertelorism,
deep-set eyes, convergent strabismus, antimongoloid slant of eyes, malformed protruding
ears, downturned corners of the mouth, dental malocclusion - Fifth finger clinodactyly,
bilateral hypoplasia of the fourth metacarpal bone, hypoplastic nails, knee and elbow valgus,
delayed bone age
Motegi et al., 1985 [17] p12-p24 tandem - Microcephaly, brachycephaly, large anterior fontanelle - Short stature - Hypertelorism,
antimongoloid slant of eyes, cup-shaped ears, prominent nasal bridge, bulbous nose,
downturned corners of the mouth, cleft lip and palate, - Small hands and feet,
hypoplastic nails
Tsezou et al., 2000 [4] p12-p24 tandem - Brachycephaly - Psychomotor delay - High forehead, hypertelorism, epicanthus,
deep-set eyes, cup-shaped ears, bulbous nasal tip, thin upper lip, downturned corners of
the mouth, micro-retrognathia, short broad neck - Syndactyly of the third and fourth fingers,




p12-p24 inverted - Brachycephaly - Psychomotor delay - Frontal bossing, hypertelorism, epicanthus,
deep-set eyes, strabismus, cup-shaped ears, bulbous nasal tip, downturned corners of
the mouth, short broad neck - Widely spaced nipples - Short upper lip, short thumbs,
transverse single palmar crease
Words in bold represents features in common with our patient
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inverted 9p spanning from 9p24 to 9p12. This variant is
rare and has been reported only once before [4]. Despite
our patient carrying one of the largest duplicated 9p seg-
ments, there is a remarkable consistency in the pheno-
type especially in the facial and digital anomalies. This
can be explained not only by the fact that 9p chromo-
some is relatively poor in genes [10], but also the dupli-
cated segment encompasses critical region defined as
9p22 as well [2].
Based on the National Center for Biotechnology Infor-
mation (NCBI) Map Viewer (www.ncbi.nlm.nih.gov/map-
view/), the duplicated region in our patient spans 39
Mb, involving 434 with only 29 annotated genes. Inter-
estingly, insulin-like growth factor binding protein-like 1
(IGFBPL1) gene localized in 9p13.1, and encoding a pro-
tein belonging to the insulin-like growth factor binding
protein (IGFBP) family. These proteins bind to insulin-like
growth factors (IGFs), and sometimes modulate the growth
effects of IGFs. IGFBPL1 was found to be most closely re-
lated to IGFBP-7 with 52 % amino acid homology and 43
% amino acid identity, and shares a similar domain struc-
ture [21]. Previous study has demonstrated that IGFBP-7
acts as an IGF-1/2 antagonist which can block insulin-like
growth factor 1 receptor (IGF1R) activation by binding to
the receptor itself [22]. Thereby, the homology between
IGFBP-1 and IGFBP-7 suggests that the overexpression of
the IGFBP-1 gene may explain the IGF-1 deficiency and
therefore the growth delay described in 9p duplication.
Conclusions
This study showed that IGF-1 deficiency can be another
feature of 9p duplication, suggesting a possible role of
IGFBPL1 overexpression in growth delay. However, fur-
ther studies of the gene expressions are needed to better
understand the phenotype-karyotype correlations.
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